General Information
Version
1.88
Revision date
2018-05-19
Product name
PROCRIT
Substance name
EPREX / PROCRIT epoetin alfa
1.2.1 Relevant identified uses
Finished Pharmaceutical Product
supplier name
Janssen Research & Development, LLC
Emergency telephone
1-800-424-9300, +1 703-527-3887
Icons in SDS
Company Information
company name
Janssen Research & Development, LLC
e-mail address of the competent person responsible for the Safety Data Sheet
SDSJanssen@its.jnj.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361
Hazard statements
Code
Statements
H361
Suspected of damaging fertility or the unborn child
Section 2
SECTION 2: Hazards identification
GHS Classification Reproductive toxicity Category 2 GHS label elements Medicinal products in the finished state, intended for the final user, are not subject to GHS label- ing
Signal word
Warning
Hazard statements
H361 Suspected of damaging fertility or the unborn child.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P281 Use personal protective equipment as required.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste dis- posal plant.
Other hazards
Avoid direct contact and significant aerosol/dust exposure which has the remote possibilities of eliciting an allergic response. May cause sensitization of susceptible personse. Refer to the pharmacotherapeutic group (section 1.2) and the patient packaging insert to evaluate the possible workplace hazards broken or crushed. when this Finished Pharmaceutical Product is accidently leaking,
Ingredient(s) with unknown acute toxicity
58.96 %
2.1 Classification of the substance or mixture
Reproductive toxicity
